Today, Galil Medical launches the Presice(TM) Cryotherapy System
for the treatment of renal and prostate cancer, at the prestigious
22nd annual European Association of Urology (EAU) Congress in Berlin,
which sets new standards in cryoablation.
A live cryosurgery satellite session, will be undertaken in
Rotenburg, on Wednesday 21st March 2007 from 09.05 - 09.30. The
surgery, using the new Presice(TM) Cryotherapy System, will be
performed by Dr Ulrich Witzsch from Krankenhaus Nordwest in Frankfurt,
and heralds a significant advance in cryotherapy.
Dr Peter Nylund, Urologist from Vassa Central Hospital in Finland
who has used the Presice(TM) Cryotherapy System on both prostate and
renal cancer patients says: "My personal experience with the
Presice(TM) Cryotherapy System is that it is very efficacious and safe
for the patients, with great clinical outcomes. In addition, my
patients have all returned home relatively quickly after the
procedure.
"The IceVue(TM) planning software in particular has made the whole
process easier, as you can view tumours in 3D and plan the positioning
of the multi thermal sensor needles, which are thinner and so allow
for a more accurate procedure."
Licensed for the cryotherapy treatment for renal and prostate
cancer, the Presice(TM) Cryoablation System revolutionises minimally
invasive cryotherapy with a state-of-the-art freezing technology,
patented 17 g needle design with sharper tips, planning and simulation
software, and streamlined workflow. The system has been designed to
achieve optimal therapeutic benefit with minimal intervention.
In December 2006, Galil Medical completed the purchase of its
cryotherapy assets from Oncura to spearhead expansion into Europe, and
its acquisition of this innovative technology is enabling the company
to expand into new therapeutic areas throughout Europe.
For further information on Galil Medical's Presice(TM) Cryotherapy
System, please contact Galil Medical directly on +44 293 459848 or go
to www.galilmedical.com.
To speak with Rosie Cunningham Thomas, President and General
Manager, or Sally Rogers, Marketing Director for Galil Medical Europe
please email at rcunninghamthomas@galilmedical.com and
sally.rogers@galilmedical.com or please contact Helena Symeou
+44(0)1923 777277. Out of normal office hours, please call +44(0)7976
562430.
